Study Links Vitamin Deficiencies to Renal Cell Carcinoma Prognosis
Overview of Renal Cell Carcinoma
A recent study highlights a correlation between low levels of vitamin A (retinol), vitamin E, and retinol binding protein (RBP4) with poor outcomes in renal cell carcinoma (RCC). RCC is the most common form of kidney cancer in adults, encompassing various tumors that develop in the nephron tissues, which are responsible for transporting urea from the blood to form urine. One of the significant challenges associated with kidney cancer is its asymptomatic nature, which complicates diagnosis until the disease reaches advanced stages. Approximately 20% of patients are diagnosed with metastatic disease.
Need for New Biomarkers
The study underscores the urgent need for new biomarkers to enhance diagnosis and prognosis in RCC. Researchers examined risk factors such as smoking and obesity, prompting an investigation into the potential relationship between nutritional deficiencies—often linked to obesity—and RCC outcomes. Insulin resistance, a key risk factor, is associated with the dysregulated production of RBP4, which serves as the primary carrier of vitamin A in the bloodstream.
Research Methodology
The current prospective observational study assessed 102 patients diagnosed with renal cell carcinoma to evaluate the correlation of preoperative RBP4, vitamin A, and vitamin E plasma levels with recurrence-free survival (RFS), overall survival (OS), and cancer-specific survival (CSS). All participants underwent surgery, whether radical or partial nephrectomy, with blood samples collected on the morning of the procedure. Plasma was separated from total blood using centrifugation, and vitamin levels were quantified via high-performance liquid chromatography (HPLC), while RBP4 levels were measured using an enzyme-linked immunosorbent assay (ELISA).
Patient Demographics and Findings
The cohort included nearly 75% males, with 25% identified as active smokers and 27% as former smokers. The mean body mass index (BMI) was 28, classifying the majority as obese, with an average age of 65 years. Notably, 75% of patients received their cancer diagnosis incidentally, with hematuria (blood in urine) being the most common symptom. At diagnosis, 10% of patients had metastatic disease, and the median follow-up period was 39 months.
Significant Predictive Findings
The study revealed that preoperative RBP4 and vitamin A levels have significant predictive value concerning survival outcomes. Patients with RBP4 levels below 21.0 mg/l exhibited a 13.5-fold increased risk of cancer-specific mortality (p=0.002). Similarly, those with vitamin A levels under 0.52 mg/l faced a 7.7-fold higher risk of RCC-specific mortality (p=0.037). Low vitamin E levels displayed a similar trend, though with less pronounced effects on mortality. The researchers emphasized the need for larger studies involving more patients and multiple blood samples to validate these preliminary findings.
Conclusion and Implications
This pioneering study examines the relationship between RBP4, vitamin A, and vitamin E levels in relation to renal cell carcinoma outcomes. The data indicates that lower levels of RBP4, vitamin A, and vitamin E at the time of diagnosis correlate strongly with reduced survival rates. The implications of these findings are significant, affecting both nutritional considerations and diagnostic approaches in renal cell carcinoma care.
Reference
Prognostic Importance of Vitamins A, E and Retinol-binding Protein 4 in Renal Cell Carcinoma Patients, Roman Sabotka et al, Anticancer Research 37: 3801-3806 (2017).